Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (61-70 of 999) with videos related to

Pageof 100
Sort By:
Atherosclerosis|May 23, 2022
Existing and emerging strategies to lower Lipoprotein(a)Gregory G Schwartz, Christie M Ballantyne
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|September 26, 1997
Epidural analgesia for labour and delivery: informed consent issuesC Pattee, M Ballantyne, B Milne
Progress in Cardiovascular Diseases|October 28, 1998
Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterolL M Belalcazar, C M Ballantyne
Nature Reviews. Cardiology|June 25, 2014
Lipid lowering with PCSK9 inhibitorsRazvan T Dadu, Christie M Ballantyne
The Journal of Clinical Endocrinology and Metabolism|November 4, 2019
Dietary and Pharmacological Fatty Acids and Cardiovascular HealthHuaizhu Wu, Lu Xu, Christie M Ballantyne
Cardiology Clinics|May 6, 2015
Genetic testing in hyperlipidemiaOzlem Bilen, Yashashwi Pokharel, Christie M Ballantyne
Clinical Therapeutics|January 11, 2005
Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trialChristie M Ballantyne, Elinor Miller, Rohini Chitra
Methodist Debakey Cardiovascular Journal|May 4, 2019
Poststatin Lipid Therapeutics: A ReviewXiaoming Jia, Patrick Lorenz, Christie M Ballantyne
Current Atherosclerosis Reports|March 27, 2024
Oral PCSK9 InhibitorsAnandita Agarwala, Ramsha Asim, Christie M Ballantyne
Endocrinology and Metabolism Clinics of North America|February 20, 2016
Genetic Testing in HyperlipidemiaOzlem Bilen, Yashashwi Pokharel, Christie M Ballantyne
Pageof 100

Showing results (61-70 of 999) with videos related to

Sort By:
Pageof 100
Atherosclerosis|May 23, 2022
Existing and emerging strategies to lower Lipoprotein(a)Gregory G Schwartz, Christie M Ballantyne
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|September 26, 1997
Epidural analgesia for labour and delivery: informed consent issuesC Pattee, M Ballantyne, B Milne
Progress in Cardiovascular Diseases|October 28, 1998
Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterolL M Belalcazar, C M Ballantyne
Nature Reviews. Cardiology|June 25, 2014
Lipid lowering with PCSK9 inhibitorsRazvan T Dadu, Christie M Ballantyne
The Journal of Clinical Endocrinology and Metabolism|November 4, 2019
Dietary and Pharmacological Fatty Acids and Cardiovascular HealthHuaizhu Wu, Lu Xu, Christie M Ballantyne
Cardiology Clinics|May 6, 2015
Genetic testing in hyperlipidemiaOzlem Bilen, Yashashwi Pokharel, Christie M Ballantyne
Clinical Therapeutics|January 11, 2005
Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trialChristie M Ballantyne, Elinor Miller, Rohini Chitra
Methodist Debakey Cardiovascular Journal|May 4, 2019
Poststatin Lipid Therapeutics: A ReviewXiaoming Jia, Patrick Lorenz, Christie M Ballantyne
Current Atherosclerosis Reports|March 27, 2024
Oral PCSK9 InhibitorsAnandita Agarwala, Ramsha Asim, Christie M Ballantyne
Endocrinology and Metabolism Clinics of North America|February 20, 2016
Genetic Testing in HyperlipidemiaOzlem Bilen, Yashashwi Pokharel, Christie M Ballantyne
Pageof 100